Elixiron Immunotherapeutics (hong Kong) Ltd.

This study tests whether a new drug called EI-001 can help people with nonsegmental vitiligo regain skin color. The drug works by calming the immune system to reduce inflammation that causes white patches. About 45 adults aged 18-65 with vitiligo for at least 3 months will receiv…

This early study tests a new drug called EI-1071 in 15 people with mild to severe Alzheimer's disease. The main goal is to see if the drug is safe and tolerable over 4 weeks, and to measure its effect on brain inflammation using special PET scans. Participants must have stable Al…